Duyster J - Search Results

1

CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML.

Waldeck S, Rassner M, Keye P, Follo M, Herchenbach D, Endres C, Charlet A, Andrieux G, Salzer U, Boerries M, Duyster J, von Bubnoff N. Waldeck S, et al. Among authors: duyster j. Mol Oncol. 2020 Apr;14(4):779-794. doi: 10.1002/1878-0261.12640. Epub 2020 Feb 13. Mol Oncol. 2020. PMID: 31955503 Free PMC article.

2

BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study.

von Bubnoff N, Schneller F, Peschel C, Duyster J. von Bubnoff N, et al. Among authors: duyster j. Lancet. 2002 Feb 9;359(9305):487-91. doi: 10.1016/S0140-6736(02)07679-1. Lancet. 2002. PMID: 11853795

3

Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes back.

von Bubnoff N, Peschel C, Duyster J. von Bubnoff N, et al. Among authors: duyster j. Leukemia. 2003 May;17(5):829-38. doi: 10.1038/sj.leu.2402889. Leukemia. 2003. PMID: 12750693 Review.

4

Inhibition of wild-type and mutant Bcr-Abl by pyrido-pyrimidine-type small molecule kinase inhibitors.

von Bubnoff N, Veach DR, Miller WT, Li W, Sänger J, Peschel C, Bornmann WG, Clarkson B, Duyster J. von Bubnoff N, et al. Among authors: duyster j. Cancer Res. 2003 Oct 1;63(19):6395-404. Cancer Res. 2003. PMID: 14559829

5

[An alternative Abl-kinase inhibitor overcomes imatinib resistance mutations of Bcr-Abl oncogenes].

Von Bubnoff N, Peschel C, Duyster J. Von Bubnoff N, et al. Among authors: duyster j. Dtsch Med Wochenschr. 2004 Oct 1;129(40):2100-3. doi: 10.1055/s-2004-831851. Dtsch Med Wochenschr. 2004. PMID: 15455301 German.

6

A cell-based screen for resistance of Bcr-Abl-positive leukemia identifies the mutation pattern for PD166326, an alternative Abl kinase inhibitor.

von Bubnoff N, Veach DR, van der Kuip H, Aulitzky WE, Sänger J, Seipel P, Bornmann WG, Peschel C, Clarkson B, Duyster J. von Bubnoff N, et al. Among authors: duyster j. Blood. 2005 Feb 15;105(4):1652-9. doi: 10.1182/blood-2004-06-2445. Epub 2004 Sep 30. Blood. 2005. PMID: 15459011 Free article.

7

A cell-based screening strategy that predicts mutations in oncogenic tyrosine kinases: implications for clinical resistance in targeted cancer treatment.

von Bubnoff N, Barwisch S, Speicher MR, Peschel C, Duyster J. von Bubnoff N, et al. Among authors: duyster j. Cell Cycle. 2005 Mar;4(3):400-6. doi: 10.4161/cc.4.3.1560. Epub 2005 Mar 25. Cell Cycle. 2005. PMID: 15738656 Review.

8

Combination of imatinib with rapamycin or RAD001 acts synergistically only in Bcr-Abl-positive cells with moderate resistance to imatinib.

Dengler J, von Bubnoff N, Decker T, Peschel C, Duyster J. Dengler J, et al. Among authors: duyster j. Leukemia. 2005 Oct;19(10):1835-8. doi: 10.1038/sj.leu.2403848. Leukemia. 2005. PMID: 15990864 No abstract available.

9

Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development.

Burchert A, Wang Y, Cai D, von Bubnoff N, Paschka P, Müller-Brüsselbach S, Ottmann OG, Duyster J, Hochhaus A, Neubauer A. Burchert A, et al. Among authors: duyster j. Leukemia. 2005 Oct;19(10):1774-82. doi: 10.1038/sj.leu.2403898. Leukemia. 2005. PMID: 16136169

10

Bcr-Abl resistance screening predicts a limited spectrum of point mutations to be associated with clinical resistance to the Abl kinase inhibitor nilotinib (AMN107).

von Bubnoff N, Manley PW, Mestan J, Sanger J, Peschel C, Duyster J. von Bubnoff N, et al. Among authors: duyster j. Blood. 2006 Aug 15;108(4):1328-33. doi: 10.1182/blood-2005-12-010132. Epub 2006 Apr 13. Blood. 2006. PMID: 16614241 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters